Legal & General Group Plc - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 224 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$2,935,659
-19.7%
58,456
+1.0%
0.00%0.0%
Q2 2023$3,657,005
+39.5%
57,864
-0.7%
0.00%0.0%
Q1 2023$2,621,251
+12.0%
58,263
+9.0%
0.00%0.0%
Q4 2022$2,341,162
-33.5%
53,439
-0.1%
0.00%0.0%
Q3 2022$3,523,000
+27.5%
53,471
-2.3%
0.00%0.0%
Q2 2022$2,763,000
-18.9%
54,708
+2.5%
0.00%0.0%
Q1 2022$3,409,000
-39.9%
53,364
+0.8%
0.00%
-50.0%
Q4 2021$5,670,000
+5.5%
52,934
+1.3%
0.00%0.0%
Q3 2021$5,374,000
+47.3%
52,278
+26.1%
0.00%
+100.0%
Q2 2021$3,648,000
+5.6%
41,471
+16.7%
0.00%0.0%
Q1 2021$3,455,000
-11.7%
35,539
+1.8%
0.00%
-50.0%
Q4 2020$3,915,000
+25.0%
34,912
+3.3%
0.00%
+100.0%
Q3 2020$3,133,000
+11.5%
33,797
-6.2%
0.00%0.0%
Q2 2020$2,810,000
+35.6%
36,037
+1.7%
0.00%0.0%
Q1 2020$2,073,000
-21.4%
35,447
+7.7%
0.00%0.0%
Q4 2019$2,636,000
+34.6%
32,902
+23.4%
0.00%0.0%
Q3 2019$1,959,000
-10.5%
26,665
+14.9%
0.00%0.0%
Q2 2019$2,190,000
+35.4%
23,207
+14.9%
0.00%0.0%
Q1 2019$1,617,000
+80.3%
20,200
+21.4%
0.00%0.0%
Q4 2018$897,000
-26.5%
16,635
+6.4%
0.00%0.0%
Q3 2018$1,221,000
+23.1%
15,6400.0%0.00%0.0%
Q2 2018$992,000
-36.0%
15,640
-7.5%
0.00%0.0%
Q1 2018$1,550,000
+14.1%
16,906
-5.8%
0.00%0.0%
Q4 2017$1,359,000
+22.7%
17,942
+12.8%
0.00%0.0%
Q3 2017$1,108,000
+126.1%
15,902
+64.0%
0.00%
Q2 2017$490,000
+108.5%
9,694
+64.8%
0.00%
Q1 2017$235,000
+88.0%
5,884
+31.8%
0.00%
Q4 2016$125,000
+43.7%
4,465
+42.9%
0.00%
Q3 2016$87,000
+38.1%
3,124
-5.8%
0.00%
Q2 2016$63,0003,3180.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2019
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders